Authors of a recent review explored the complex relationship between CKD, COVID-19, and anemia and offered practice points based on clinical experience. Patients with chronic kidney disease (CKD) ...

Editor’s note: This is an automatically generated transcript. Please notify editor@healio.com if there are concerns regarding accuracy of the transcription. Well, the first step is diagnosis. We have ...

Nonetheless, the number of CKD-related anemia cases continues to increase, due to population growth, aging, and other factors. Anemia cases attributable to chronic kidney disease (CKD) continue to ...

In this study, both anemia and chronic kidney disease were highly prevalent among HF patients discharged from two university hospitals and independently associated with an increased risk of dying in ...

Ziltivekimab, an anti-IL-6 ligand antibody, increases iron and other anemia parameters in patients with chronic kidney disease. Ziltivekimab, a novel anti-IL-6 ligand antibody, improves ...

During the median follow-up of 2.5 years, 2887 and 429 composite anemia outcomes were recorded in patients receiving SGLT2 inhibitors and GLP-1 RAs, respectively. The incidence rate of composite ...

Treatment with vadadustat was noninferior to darbepoetin alfa in correcting and maintaining Hb levels in adults with incident dialysis-dependent CKD. The Food and Drug Administration (FDA) has ...

Editor’s note: This is an automatically generated transcript. Please notify editor@healio.com if there are concerns regarding accuracy of the transcription. Let's start with what causes anemia of ...

SGLT2 inhibitors significantly improve hemoglobin and hematocrit levels in CKD patients, enhancing anemia management. The KDIGO 2024 guideline endorses SGLT2 inhibitors for CKD patients, highlighting ...

Insilico Medicine has licensed TaiGen Biotechnology exclusive rights in the Greater China area to develop, commercialize, and sub-license ISM4808, an AI-driven potential best-in-class oral PHD ...